(Bold for FDA approved)
• Blocks dopamine 2 receptors, reducing positive symptoms of psychosis
• Psychotic symptoms can improve within 1 week, but it may take several weeks for full effect on behavior
• Neuroleptic-induced deficit syndrome
• Akathisia
• Drug-induced parkinsonism
• Tardive dyskinesia
• Risk of potentially irreversible involuntary dyskinetic movements may increase with cumulative dose and treatment duration
• Galactorrhea, amenorrhea
• Sedation
• Dry mouth, constipation, vision disturbance, urinary retention
• Hypotension, tachycardia
• Rare fine lenticular pigmentation
• Rare neuroleptic malignant syndrome may cause hyperpyrexia, muscle rigidity, delirium, and autonomic instability with elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure
• Rare seizures
• Rare blood dyscrasias
• Rare hepatic toxicity
• As a class, antipsychotics are associated with an increased risk of death and cerebrovascular events in elderly patients with dementia; not approved for treatment of dementia-related psychosis
unusual
not usual
• Wait
• Wait
• Wait
• For drug-induced parkinsonism, add an anticholinergic agent
• Beta blockers, benzodiazepines, or serotonin 2A antagonists (e.g., mirtazapine, cyproheptadine) may reduce akathisia
• For sedation, take at night
• Reduce the dose
• Switch to an atypical antipsychotic
• Weight loss, exercise programs, and medical management for high BMIs, diabetes, dyslipidemia
• Metformin may help prevent or reverse antipsychotic-induced weight gain
• 15–30 mg/day
• Capsule 2 mg, 5 mg, 10 mg
• Should periodically reevaluate long-term usefulness in individual patients, but treatment may need to continue for many years
• No
• Use with caution
• Use with caution
• Thiothixene may cause or aggravate ECG changes
• Use in patients with cardiac impairment has not been studied, so use with caution because of risk of orthostatic hypotension
• Use with caution if patient is taking concomitant antihypertensive or alpha 1 antagonist
• Some patients may tolerate lower doses better
• Although conventional antipsychotics are commonly used for behavioral disturbances in dementia, no agent has been approved for treatment of elderly patients with behavioral symptoms of dementia such as agitation
• Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo, and also have an increased risk of cerebrovascular events
• Safety and efficacy have not been established in children under age 12
• Generally consider second-line after atypical antipsychotics
• Controlled studies have not been conducted in pregnant women
• There is a risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers took an antipsychotic during the third trimester; symptoms may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty feeding
• Reports of drug-induced parkinsonism, jaundice, hyperreflexia, hyporeflexia in infants whose mothers took a phenothiazine during pregnancy
• Psychotic symptoms may worsen during pregnancy and some form of treatment may be necessary
• Atypical antipsychotics may be preferable to conventional antipsychotics or anticonvulsant mood stabilizers if treatment is required during pregnancy
• Thiothixene should generally not be used during the first trimester
• Thiothixene should be used during pregnancy only if clearly needed
• Unknown if thiothixene is secreted in human breast milk, but all psychotropics are assumed to be secreted in breast milk
• Recommended either to discontinue drug or bottle feed
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera